← All trials
NCT05366101
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2019
- Primary completion
- Feb 28, 2022
- Completion date
- Mar 31, 2022
- First posted
- May 9, 2022
- Last posted
- May 9, 2022
- Enrollment
- 168
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Newcastle UniversityLead sponsor
- Newcastle UniversityOverall official - principal investigator
- Newcastle UniversityReponsible party - principal investigator
- University of FlorenceCollaborator
- University of RegensburgCollaborator
- Assistance Publique - Hôpitaux de ParisCollaborator
- Institute for Cardiovascular Diseases of VojvodinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.